Mechanisms of Rejection and Prolongation of Vascularized Organ Allografts

Immunological Reviews

Volumn 77, Issue 1, 1984, Pages 185-216

  Tilney, N L ^a   Kupiec Weglinski J W ^a   Heidecke, C D ^a   Lear, P A ^a   Strom, T B ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOKINE; MONOCLONAL ANTIBODY; CYCLOSPORIN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BIOLOGICAL MODEL; CELL INFILTRATION; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; ETIOLOGY; GRAFT REJECTION; HEART; HEART TRANSPLANTATION; IN VITRO STUDY; LYMPHOCYTE SUBPOPULATION; METHODOLOGY; NONHUMAN; RAT; ALLOTRANSPLANTATION; ANIMAL; ANTIBODY PRODUCTION; ARTICLE; BLOOD VESSEL; CELLULAR IMMUNITY; GRAFT SURVIVAL; HUMAN; IMMUNIZATION; IMMUNOLOGY; KIDNEY TRANSPLANTATION; LYMPHOCYTE; LYMPHOID TISSUE; NEUTROPHIL CHEMOTAXIS; PASSIVE IMMUNIZATION; SKIN TRANSPLANTATION; SUPPRESSOR CELL; TRANSPLANTATION;

ANIMAL; ANTIBODY FORMATION; BLOOD VESSELS; CHEMOTAXIS, LEUKOCYTE; CYCLOSPORINS; GRAFT ENHANCEMENT, IMMUNOLOGIC; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; IMMUNITY, CELLULAR; IMMUNIZATION; IMMUNIZATION, PASSIVE; KIDNEY TRANSPLANTATION; LYMPHOCYTES; LYMPHOID TISSUE; RATS; SKIN TRANSPLANTATION; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, SUPPRESSOR-EFFECTOR; TRANSPLANTATION, HOMOLOGOUS;

EID: 0021289306     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1984.tb00722.x     Document Type: Article

References (144)

1. Microvascular changes in lymph nodes draining skin grafts
2. Partial characterization of cytotoxic cells infiltrating sponge‐matrix allografts
3. Evidence for local helper and suppressor function at the site of allograft rejection
4. Cellular events within the rejecting allograft
5. Thymus‐dependent lymphocytes in tissue sections of rejecting rat renal allografts.
6. Enhanced allograft survival by combined active and passive immunization: requirement of both erythrocytes and leukocytes
7. Immune responses to organ allografts. I. Intense B‐cell response to heart allografts in lymphoid tissues of unmodified rats
8. Immune responses to organ allografts. II Decreased B‐cell responses to cardiac allografts in rats pretreated with enhancing, suppressor cell, or T‐lymphocyte depletion protocol
9. Immune responses to organ allografts. III Marked decrease in medullary thymocytes and splenic T‐lymphocytes following cyclosporin A treatment
10. Selection localization of cortical thymocytes to cardiac allografts in enhanced rats
11. The role of afferent lymphatics in the rejection of skin homografts
12. Histocompatibility requirements of heart and skin grafts in rats
13. Cellular and humoral immunity after allogeneic transplantation in the rat. The effect of passive antibody on cellular and humoral immunity after allogeneic renal transplantation
14. Quantitative studies on tissue transplantation immunity
15. The passenger cell concept in transplantation immunology
16. Influence of selective splenectomy on survival of cardiac and skin allografts in enhanced rats
17. Differential effects of heterologous antisera on the survival of cardiac and skin allografts in rats
18. Cyclosproin A: A more specific immunosuppressive agent
19. Function and migration of suppressor lymphocytes from Cyclosporin‐treated heart graft recipients
20. Kinetics of Cyclosporin A‐induced unresponsiveness to cardiac allografts in rats
21. Effect of the anti‐lymphocyte peptide Cyclosporin A
22. Cyclosporin A: In vivo and in vitro suppression of rat T‐lymphocyte function
23. Cyclosporin A mediates immunosuppression of Interleukin 1 and Interleukin 2
24. Human renal allografts: analysis of lesions in long‐term survivors
25. Human renal allografts: The role of vascular injury in early graft failure.
26. Variant forms of arteritis inhuman renal allografts
27. Two distinct pools of recirculating lymphocytes; migratory characteristic of nodal and intestinal T‐lymph‐ocytes
28. Assessment of T‐cell function with a skin allograft assay
29. Mechanisms of rejection: Update 1982
30. Restoration of allograft responsiveness in B rats by Interleukin 2 and/or adherent cells
31. Demonstration and phenotypic characterization of HLA‐ DR‐Positive interstitial dendritic cells widely distributed in human connective tissues
32. The roles of host and donor cells in the rejection of skin allografts by T‐cell‐deprived rats injected with syngeneic T‐cells
33. Role of thymus‐derived and thymus‐independent cells in murine skin allograft rejection
34. The level of Fc receptor leukocytes in primary and secondary skin allograft recipients
35. The fate of Interleukin 2 after in vivo administration
36. The adoptive transfer of first‐set allograft responses by recirculating small lymphocytes in the rat
37. Expression of T‐cell differentiation antigens and la or rat cytotoxic lymphocytes
38. Generation of cytolytic T‐lymphocytes in thymectomized, irradiated and bone‐marrow‐reconstituted mice
39. Antigen‐induced increase in migration of large cortical thymocytes (regulatory cells) to the marginal zone and red pulp of the spleen
40. Immunologically‐specific retention of long‐lived lymphoid cells in antigenically stimulated lymph nodes
41. The effect of donor strain blood pretreatment on renal allograft rejection in rats
42. Induction of cytocidal macrophages after in vitro interactions between Listeria‐immune T‐cells and macro‐ phages ‐ Role of H‐2
43. Renal homotransplantation in rats
44. Lymphocyte migration and immune responses
45. Macrophage migration stimulation factor and migration inhibition factor and the role of suppressor cells in their production
46. Anti‐la antibody eluted from rejected human renal allografts
47. Antibody‐producing cells are generated in mixed lymphocyte culture
48. Immunoglobulin‐ secreting cells recovered from rejected human renal allografts
49. Potentiation of lymphocyte responses to mitogens. II The cellular source of potentiating mediators
50. Migration of lymphocytes and thymocytes in the rat. IT Circulation of lymphocytes and thymocytes from blood to lymph
51. The route of recirculation of lymphocytes in the rat
52. Extensive prolongation of rabbit kidney allograft survival after short‐term Cyclosporin A treatment
53. Renal transplantation in the inbred rat
54. Studies of the cells in the afferent and efferent lymph of lymph nodes draining the site of skin homografts
55. The cellular basis of allograft rejection in vivo. 1 The cellular requirements for first‐set rejection of heart grafts
56. Effect of Cyclosporin A on human lymphocyte responses in vitro. IV Production of T‐cell stimulating growth factors and development of responsiveness to these growth factors in CsA‐treated primary MLR cultures
57. Collection of lymph from kidneys transplanted in man: Cell transformation in vivo
58. Recruitment of unsensitized circulating lymphocytes to sites of allogeneic cellular interactions
59. Lyt‐23+ Cyclophosphamide‐sensitive T‐ cells regulate the activity of an Interleukin‐2 inhibitor in viva
60. In situ effector mechanisms in rat kidney allograft rejection. III Kinetics of the inflammatory response and generation of donor‐directed killer cells
61. In vivo Interleukin‐2 administration augments the generation of alloreactive cytolytic T‐lymphocytes and resident natural killer cells
62. Transfer of specific unresponsiveness to organ allografts by thymocytes
63. Effect of Cyclosporin A on human lymphocyte responses in vitro. II Induction of specific alloantigen unresponsiveness by nylon wool‐adherent suppressor cells
64. Progressive destruction of renal homografts isolated from the regional lymphatics of the host
65. Cyclosporin A spares selectively lymphocytes with donor‐specific suppressor characteristics
66. Quantitative data concerning the development of the cellular infiltration of skin allograft in mice
67. Long‐term human cylolytic T‐cell lines allospecific for HLA‐DR6 antigen arc 0KT4+
68. Migration patterns of lymphocytes from recipients of organ allografts. I. The unmodified host
69. Changes in lymphocyte migration patterns after heart grafting in rats
70. Importance of thymocyte migration in cyclosporine‐treated heart graft recipients
71. Acute rejection in Cyclosporin A‐treated graft recipient occurs following abrogation of suppressor cells
72. Homing of specifically sensitized lymphocytes to allografts of skin
73. In vitro activity of subpopulations of immune lymphocytes against murine sarcoma cells
74. Differential effects of Cyclosporin A on lymphocyte subpopulations
75. Restoration of altograft responsiveness in B rats. II Requirements for both lymphoid populations and lymphokine
76. The vascular reaction in the free skin allo‐ and autographs,
77. Cells mediating graft rejection in the mouse. I Lyt‐1 cells mediate skin graft rejection
78. Delayed‐type hypersensitivity and allograft rejection in the mouse: correlation of the effector phenotype
79. Which T‐cells cause graft rejection
80. Delayed‐Type hypersensitivity and lymphocytotoxicity in cardiac allograft rejection
81. Presence of splenic suppressor cells in allograft enhanced rats
82. The mechanism of allograft rejection ‐ Progress and problems
83. Behavior and fate of skin autografts and skin homografts in rabbits
84. The homgraft reaction
85. + effector cells recognize products of different major histocompatibility complex regions
86. Suppression of renal allograft rejection by low‐density thymocytes
87. Reassortment of lymphocytes in lymph from normal and allograft sheep
88. Studies on the immunological response to foreign tumor transplants in the mouse
89. A new antigen system expressed in human endothelial cells
90. Kinetics of unresponsiveness induced by a short course of cyclosporin A
91. Whole body localization of intravenously injected lymphoblasts in normal rats
92. 3H‐cytidine
93. The role of the lymphatic system in the rejection of homografts: A study of lymph from renal transplants
94. Recirculation lymphocytaire chezl'homme normal
95. Tolerance and contact sensitivity to DNFB in mice. III. Transfer of tolerance with “suppressor T‐cells.”
96. Cellular specificity in the homograft reaction
97. Physiology of lymphocyte recirculation in animal models
98. Recirculation of lymphocytes; its role in implementing immune responses in the skin
99. An experimental comparison of radioactive labels with potential application to lymphocyte migration studies in patients
100. Lymphoid cell subclasses in rejecting renal allograft in the rat
101. Effector mechanisms in allograft rejection. 1 Assembly of sponge‐matrix allografts
102. Sponge‐matrix allografts: a model for analysis of killer cells infiltrating mouse allografts
103. Immune response in rats deficient in thymus‐derived lymphocytes to strong transplantation antigens (AgB)
104. In vivo administration of InterIeukin‐2 enhances specific alloimmune responses
105. Effects of Cyclosporin A on suppressor and inducer T‐lymphocytes in primary biliary cirrhosis
106. Migration patterns of lymphocytes from recipients of organ aliografts. II. The enhanced host
107. Studies on the lymphocytes of sheep. II. Some properties of cells in various compartments of the recirculating lymphocyte pool
108. Cellular changes in lymph ndes and spleen following skin homografting in the rabbit
109. Biological incompatibility in kidney transplantation in dogs. I. Experimental and morphological investigations
110. The role of non‐classical Fc receptor‐associated Ag‐B antigens (Ia) in rat allograft enhancement
111. Prolongation of rat cardiac allograft survival by splenectomy following transplantation
112. Relationship of cell cycle to recovery of IL‐2 activity from human mononuclear cells, human and mouse T‐cell lines
113. Effect of surgical ablation of regional lymph nodes on survival of skin homografts
114. Studies with a monoclonal antibody to mouse dendritic cells
115. The role of lymphatics in the sensitization of rats to renal homografts
116. Identity and cytotoxic capacity of cells infiltrating renal allografts
117. Modification of the rat alloimmune response by enhancing antibodies and the role of blocking factors in the survival of renal allografts
118. Cellular components of allograft rejection: identity, specificity, and cytotoxic function of cells infiltrating acutely rejecting allografts
119. A characterization of the nature and control of cellular allograft rejection
120. Intragraft immune events causing vascularized organ graft rejection
121. Immunologic enhancement of renal allografts in the rat
122. Specific suppression of renal allograft rejection by treatment with antigen and antibody
123. Cellular and humoral activity after allogeneic renal transplantation in the rat. Appearance of anti‐idiotype antibody and the relationship to cellular immunity after treatment with donor spleen cells and alloantibody
124. Immunological enhancement of renal allografts by anti‐receptor antibody
125. Considerations in immunologic monitoring of long‐term transplant recipients
126. The sensitization of rats by allografts transplanted to alymphatic pedicles of skin
127. Studies on enhancement of cardiac and renal allografts in the rat
128. Host cell proliferation in response to skin allografts on alymphatic pedicles
129. The migration of rat lymphoid cells into skin grafts: Some sensitized cells localize preferentially in specific allografts
130. Surface properties and functional characteristics of infiltrating cells harvested from acutely rejecting cardiac allografts in inbred rats
131. Host response to cardiac allografts in rats. Effect of thymectomy, irradiation, T‐cell depletion, or AgB compatability
132. Studies on infiltrating host cells harvested from acutely rejecting rat cardiac allografts
133. Specificity of cellular migration into cardiac allografts in rats
134. Prolongation of organ allograft survival by syngeneic lymphoid cells
135. Enhancement of cardiac allografts in rats; comparison of the responses to different treatment protocols
136. Rejected human renal allografts
137. Effects of thymectomy, thoracic duct drainage and radiation on T‐ and B‐lymphocyte distribution and cardiac allograft survival in rats
138. Use of Cyclosporin A in allogeneic bone‐marrow transplantation in the rat
139. Role of the thymus in immune reactions in rats. III Changes in the lymphoid tissues in thymectomized rats
140. Evidence for the presence of suppressor T‐lymphocytes in animals treated with Cyclosporin A
141. Suppressive effects of Cyclosporin A on the induction of alloreactivity in vitro and in vivo
142. In situ effector mechanisms in rat kidney allograft rejection. I. Characterization of the host cellular infiltrate in rejecting allograft parenchyma